|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
84,540,000 |
Market
Cap: |
346.61(M) |
Last
Volume: |
34,905,322 |
Avg
Vol: |
12,269,127 |
52
Week Range: |
$4.1 - $4.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mckinney Robert A |
Chief Financial Officer |
|
2008-10-01 |
4 |
D |
$13.93 |
$17,259 |
D/D |
(1,239) |
39,002 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2008-10-01 |
4 |
OE |
$6.53 |
$11,878 |
D/D |
1,819 |
40,241 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2008-09-03 |
4 |
AS |
$15.00 |
$15,000 |
D/D |
(1,000) |
39,801 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2008-09-03 |
4 |
OE |
$12.29 |
$12,290 |
D/D |
1,000 |
40,801 |
|
- |
|
Briner Kurt W |
Director |
|
2008-08-28 |
4 |
OE |
$9.63 |
$481,250 |
D/D |
50,000 |
53,000 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2008-08-01 |
4 |
AS |
$16.47 |
$16,465 |
D/D |
(1,000) |
39,801 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2008-08-01 |
4 |
OE |
$12.29 |
$12,290 |
D/D |
1,000 |
40,801 |
|
- |
|
Jacobson Paul F |
Director |
|
2008-07-15 |
4 |
S |
$16.04 |
$160,350 |
D/D |
(10,000) |
188,000 |
|
- |
|
Jacobson Paul F |
Director |
|
2008-07-15 |
4 |
OE |
$4.41 |
$68,820 |
D/D |
10,000 |
190,500 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,667 |
36,622 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2008-07-01 |
4 |
D |
$16.05 |
$33,528 |
D/D |
(2,089) |
29,955 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2008-07-01 |
4 |
OE |
$13.64 |
$31,317 |
D/D |
2,296 |
32,044 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,667 |
39,801 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2008-07-01 |
4 |
AS |
$15.59 |
$15,592 |
D/D |
(1,000) |
33,134 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2008-07-01 |
4 |
OE |
$12.29 |
$53,715 |
D/D |
4,037 |
34,134 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2008-07-01 |
4 |
D |
$16.05 |
$44,362 |
D/D |
(2,764) |
33,134 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
720,148 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
37,913 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2008-07-01 |
4 |
D |
$16.05 |
$42,661 |
D/D |
(2,658) |
29,580 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2008-07-01 |
4 |
OE |
$13.64 |
$39,842 |
D/D |
2,921 |
32,238 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,667 |
36,205 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2008-07-01 |
4 |
D |
$16.05 |
$42,661 |
D/D |
(2,658) |
29,538 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2008-07-01 |
4 |
OE |
$13.64 |
$39,842 |
D/D |
2,921 |
32,196 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2008-07-01 |
4 |
D |
$16.05 |
$71,053 |
D/D |
(4,427) |
25,925 |
|
- |
|
Baker Mark Robert |
General Counsel |
|
2008-07-01 |
4 |
OE |
$13.64 |
$66,359 |
D/D |
4,865 |
30,352 |
|
- |
|
801 Records found
|
|
Page 11 of 33 |
|
|